About iCardiac Technologies
iCardiac Technologies is a company based in Rochester (United States) founded in 2006 was acquired by Clario in December 2017. iCardiac Technologies has raised $4 million across 3 funding rounds from investors including Norwest Venture Partners, Clario and Advantage Capital. iCardiac Technologies operates in a competitive market with competitors including Celerion, Altasciences, Ask Gene Pharma, Open Orphan and AWAKN, among others.
- Headquarter Rochester, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Norwest Venture Partners
& 5 more
-
Employee Count
Not available
-
Acquired by
Clario
(Dec 04, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iCardiac Technologies
iCardiac Technologies has successfully raised a total of $4M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in iCardiac Technologies
iCardiac Technologies has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Norwest Venture Partners, Clario and Advantage Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for iCardiac Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by iCardiac Technologies
Investment portfolio details for iCardiac Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - iCardiac Technologies
Detailed financials for iCardiac Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Icardiac Technologies Comparisons
Peer comparison for iCardiac Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of iCardiac Technologies
iCardiac Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Altasciences, Ask Gene Pharma, Open Orphan and AWAKN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early clinical research services are provided for drug development.
|
|
| Locked | Locked | Locked |
Early phase clinical research services are provided in North America.
|
|
| Locked | Locked | Locked |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| Locked | Locked | Locked |
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
|
| Locked | Locked | Locked |
CRO focused on early stage clinical trial research
|
Detailed competitors of iCardiac Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Icardiac Technologies
Complete news archive for iCardiac Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iCardiac Technologies
iCardiac Technologies was founded in 2006.
iCardiac Technologies is headquartered in Rochester, United States.
iCardiac Technologies is a funded company, having raised a total of $4M across 3 funding rounds to date.
iCardiac Technologies was founded in 2006 in Rochester, United States, within the biopharmaceutical sector. ECG core laboratory services for cardiac safety assessments are offered, utilizing the iClinica platform to analyze data from First-in-Human to Phase III studies, including Thorough QT evaluations. Respiratory and electronic patient-reported outcome services were added through the 2015 acquisition of nSpire Healths clinical trials division. Operations support major biopharma firms alongside smaller entities.
iCardiac Technologies's top competitors include Celerion, Ask Gene Pharma and HMR London.
iCardiac Technologies has 6 investors. Key investors include Norwest Venture Partners, Clario, Advantage Capital, Trillium Group, and Stonehenge Growth Equity Partners.